611 related articles for article (PubMed ID: 34237822)
1. The role of inflammation in diabetic kidney disease.
Jung SW; Moon JY
Korean J Intern Med; 2021 Jul; 36(4):753-766. PubMed ID: 34237822
[TBL] [Abstract][Full Text] [Related]
2. Update of pathophysiology and management of diabetic kidney disease.
Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
[TBL] [Abstract][Full Text] [Related]
3. The future of diabetic kidney disease management: what to expect from the experimental studies?
Barutta F; Bellini S; Corbetta B; Durazzo M; Gruden G
J Nephrol; 2020 Dec; 33(6):1151-1161. PubMed ID: 32221858
[TBL] [Abstract][Full Text] [Related]
4. Update on role of direct renin inhibitor in diabetic kidney disease.
Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.
Chen X; Li X; Cao B; Chen X; Zhang K; Han F; Kan C; Zhang J; Sun X; Guo Z
Int Urol Nephrol; 2024 Feb; 56(2):571-582. PubMed ID: 37552392
[TBL] [Abstract][Full Text] [Related]
6. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
[TBL] [Abstract][Full Text] [Related]
7. Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules.
Tang J; Liu F; Cooper ME; Chai Z
Expert Opin Ther Targets; 2022 Aug; 26(8):721-738. PubMed ID: 36217308
[TBL] [Abstract][Full Text] [Related]
8. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
Barrera-Chimal J; Jaisser F
Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
[TBL] [Abstract][Full Text] [Related]
10. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.
Xu C; Ha X; Yang S; Tian X; Jiang H
Front Endocrinol (Lausanne); 2023; 14():1232790. PubMed ID: 37859992
[TBL] [Abstract][Full Text] [Related]
11. Diabetic Kidney Disease.
Bonner R; Albajrami O; Hudspeth J; Upadhyay A
Prim Care; 2020 Dec; 47(4):645-659. PubMed ID: 33121634
[TBL] [Abstract][Full Text] [Related]
12. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL; Odum LE; Whaley-Connell AT
Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
[TBL] [Abstract][Full Text] [Related]
13. Targeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?
Leehey DJ
Kidney360; 2020 Apr; 1(4):292-299. PubMed ID: 35372914
[TBL] [Abstract][Full Text] [Related]
14. The genetic side of diabetic kidney disease: a review.
Song J; Ni J; Yin X
Int Urol Nephrol; 2023 Feb; 55(2):335-343. PubMed ID: 35974289
[TBL] [Abstract][Full Text] [Related]
15. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.
Pichler R; Afkarian M; Dieter BP; Tuttle KR
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F716-F731. PubMed ID: 27558558
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and Diabetic Kidney Disease.
Huang HY; Lin TW; Hong ZX; Lim LM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835159
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.
Eid SA; Hinder LM; Zhang H; Eksi R; Nair V; Eddy S; Eichinger F; Park M; Saha J; Berthier CC; Jagadish HV; Guan Y; Pennathur S; Hur J; Kretzler M; Feldman EL; Brosius FC
FASEB J; 2021 May; 35(5):e21467. PubMed ID: 33788970
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in drug discovery for diabetic kidney disease.
Danta CC; Boa AN; Bhandari S; Sathyapalan T; Xu SZ
Expert Opin Drug Discov; 2021 Apr; 16(4):447-461. PubMed ID: 33003971
[TBL] [Abstract][Full Text] [Related]
19. [Current developments in renal failure in diabetic patients].
Lindenmeyer M
Praxis (Bern 1994); 2015 Feb; 104(4):187-95. PubMed ID: 25669223
[TBL] [Abstract][Full Text] [Related]
20. Renin-Angiotensin-Aldosterone system blockade in diabetic kidney disease: A critical and contrarian point of view.
Elrggal ME; Ahmed SM; El Nahas M
Saudi J Kidney Dis Transpl; 2016; 27(6):1103-1113. PubMed ID: 27900954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
